UPC: 9781475776317 | Cancer Treatment and Research: Atlas of Selective Sentinel Lymphadenectomy for Melanoma Breast Cancer and Colon Cancer (Paperback)
- At amazon.com you can purchase Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer (Cancer Treatment and Research, 111) for only 0.00
- The lowest price of Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer (Cancer Treatment and Research, 111) was obtained on July 27, 2024 6:50 am.
![UPC: 9781475776317 | Cancer Treatment and Research: Atlas of Selective Sentinel Lymphadenectomy for Melanoma Breast Cancer and Colon Cancer (Paperback)](https://i5.walmartimages.com/asr/52fd44d4-6083-4591-aa8e-5afa0e17975d.3ec5b31b0c63c12ed921f96d2cc86a9b.jpeg?odnHeight=450&odnWidth=450&odnBg=ffffff)
Description
UPC lookup results for: 9781475776317 | Cancer Treatment and Research: Atlas of Selective Sentinel Lymphadenectomy for Melanoma Breast Cancer and Colon Cancer (Paperback)
Atlas of Selective Lymphadenectomy for Melanoma Breast Cancer and Colon Cancer emphasizes a multidisciplinary approach combining the experiences of a nuclear medicine physician surgeon and pathologist. This is an important reference also for researchers and clinicians who want to become familiar with sentinel lymph node mapping. The underlying thesis in solid tumor biology is that metastasis in general starts in an orderly progression with lymphatic spread first to the sentinel lymph node (SLN) in the nearest lymph node basin. Therefore the logical approach is to harvest that specific SLN for thorough analysis.
UPC: 9781475776317 | Cancer Treatment and Research: Atlas of Selective Sentinel Lymphadenectomy for Melanoma Breast Cancer and Colon Cancer (Paperback) Prices
Price History
Reviews (0)
User Reviews
Be the first to review “UPC: 9781475776317 | Cancer Treatment and Research: Atlas of Selective Sentinel Lymphadenectomy for Melanoma Breast Cancer and Colon Cancer (Paperback)”
You must be logged in to post a review.
There are no reviews yet.